HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I A Cree Selected Research

Gemcitabine

6/2005Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.
12/2003Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.
12/2001Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.
11/2000The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I A Cree Research Topics

Disease

11Melanoma (Melanoma, Malignant)
06/2007 - 06/2000
8Uveal melanoma
07/2006 - 06/2000
5Ovarian Neoplasms (Ovarian Cancer)
10/2013 - 05/2000
4Neoplasms (Cancer)
07/2011 - 07/2000
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2008 - 04/2005
2Colorectal Neoplasms (Colorectal Cancer)
07/2011 - 12/2003
2Carcinoma (Carcinomatosis)
07/2011 - 11/2000
2Acanthamoeba Keratitis
10/2009 - 03/2001
2Retinal Perforations
02/2008 - 04/2005
2Cataract (Cataracts)
06/2006 - 07/2000
2Monosomy
12/2000 - 10/2000
1Adenoma (Adenomas)
07/2011
1Polyps
07/2011
1Ulcer
10/2009
1Leukostasis
02/2008
1Neoplasm Metastasis (Metastasis)
06/2007
1Macular Degeneration (Age-Related Maculopathy)
06/2006
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2003
1Retinal Detachment (Retinal Detachments)
04/2002
1Melanosis (Freckles)
10/2001
1Dry Eye Syndromes (Dry Eye Syndrome)
04/2001
1Inflammation (Inflammations)
03/2001
1Infections
03/2001
1Orbital lymphoma
12/2000
1Cardiotoxicity
11/2000
1Ovarian Epithelial Carcinoma
05/2000

Drug/Important Bio-Agent (IBA)

5Adenosine Triphosphate (ATP)IBA
04/2002 - 05/2000
4CytokinesIBA
02/2008 - 04/2002
4GemcitabineFDA Link
06/2005 - 11/2000
3treosulfanIBA
06/2005 - 07/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2005 - 04/2002
3Paclitaxel (Taxol)FDA LinkGeneric
12/2001 - 05/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2001 - 10/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2006 - 04/2002
2Drug CombinationsIBA
12/2001 - 05/2000
2Mitoxantrone (Novantrone)FDA LinkGeneric
12/2001 - 10/2000
2AntigensIBA
10/2001 - 03/2001
2Pharmaceutical PreparationsIBA
04/2001 - 05/2000
2AnthracyclinesIBA
11/2000 - 10/2000
2Cisplatin (Platino)FDA LinkGeneric
07/2000 - 05/2000
1ErbB Receptors (EGF Receptor)IBA
10/2013
1ZSTK474IBA
10/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2013
1Gefitinib (Iressa)FDA Link
10/2013
1Sirolimus (Rapamycin)FDA Link
10/2013
1DNA (Deoxyribonucleic Acid)IBA
07/2011
1Genetic Markers (Genetic Marker)IBA
07/2011
1PlatinumIBA
08/2010
1Endothelin-1 (Endothelin 1)IBA
02/2008
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2008
1VaccinesIBA
06/2007
1EnzymesIBA
06/2007
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2007
1Interleukin-10 (Interleukin 10)IBA
06/2007
1Transforming Growth Factor-beta Type I ReceptorIBA
06/2007
1Protons (Proton)IBA
07/2006
1Angiopoietin-1IBA
04/2005
1Angiopoietin-2IBA
04/2005
1AngiopoietinsIBA
04/2005
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2003
1Transforming Growth Factor alpha (TGF-alpha)IBA
10/2002
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2002
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2002
1AntibodiesIBA
04/2002
1Vinorelbine (Navelbine)FDA LinkGeneric
12/2001
1Cytotoxins (Cytolysins)IBA
12/2001
1Formaldehyde (Formol)FDA Link
10/2001
1Transforming Growth Factor beta (TGF-beta)IBA
12/2000
1liposomal doxorubicin (Doxil)FDA Link
11/2000
1Alkylating AgentsIBA
11/2000
1Topoisomerase II InhibitorsIBA
10/2000
1Type II DNA Topoisomerases (Topoisomerase II)IBA
10/2000
1Vincristine (Oncovin)FDA LinkGeneric
10/2000
1Protein Isoforms (Isoforms)IBA
10/2000
1acridine DACAIBA
07/2000
1ApoferritinsIBA
07/2000
1Topoisomerase InhibitorsIBA
07/2000
1Carboplatin (JM8)FDA LinkGeneric
05/2000
1Epirubicin (Ellence)FDA LinkGeneric
05/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2000

Therapy/Procedure

6Drug Therapy (Chemotherapy)
08/2010 - 06/2000
3Therapeutics
04/2002 - 11/2000
2Radiotherapy
07/2006 - 12/2000
1Contact Lenses
10/2009
1Proton Therapy
07/2006
1Brachytherapy
07/2006
1Phacoemulsification
06/2006
1Intraocular Lenses (Intraocular Lens)
06/2006
1Vitrectomy
04/2005
1Combination Drug Therapy (Combination Chemotherapy)
12/2003
1Cataract Extraction
04/2002